Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors – Results from the PAN Study

por Stahmeyer, Jona T., Rossol, Siegbert, Bert, Florian, Böker, Klaus H. W., Bruch, Harald-Robert, Eisenbach, Christoph, Link, Ralph, John, Christine, Mauss, Stefan, Heyne, Renate, Schott, Eckart, Pfeiffer-Vornkahl, Heike, Hüppe, Dietrich, Krauth, Christian
Publicado 2016

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting

por Wiegand, Steffen B., Heidrich, Benjamin, Susser, Simone, Rogalska-Taranta, Magdalena, Petersen, Jörg, Böker, Klaus H. W., Grigorian, Natalia, Link, Ralph, Naumann, Uwe, John, Christine, Lueth, Stefan, Malfertheiner, Peter, Manns, Michael P., Wedemeyer, Heiner, Sarrazin, Christoph, Cornberg, Markus
Publicado 2015

Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective,...

por Heidrich, Benjamin, Cordes, Hans-Jörg, Klinker, Hartwig, Möller, Bernd, Naumann, Uwe, Rössle, Martin, Kraus, Michael R., Böker, Klaus H., Roggel, Christoph, Schuchmann, Marcus, Stoehr, Albrecht, Trein, Andreas, Hardtke, Svenja, Gonnermann, Andrea, Koch, Armin, Wedemeyer, Heiner, Manns, Michael P., Cornberg, Markus
Publicado 2015

Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA

por Heidrich, Benjamin, Wiegand, Steffen B., Buggisch, Peter, Hinrichsen, Holger, Link, Ralph, Möller, Bernd, Böker, Klaus H. W., Teuber, Gerlinde, Klinker, Hartwig, Zehnter, Elmar, Naumann, Uwe, Busch, Heiner W., Maasoumy, Benjamin, Baum, Undine, Hardtke, Svenja, Manns, Michael P., Wedemeyer, Heiner, Petersen, Jörg, Cornberg, Markus
Publicado 2014